Dysfunctional Red Blood Cells in Children Identified as a Potential Root Cause of Lupus
Research Funded by the Lupus Research Alliance Published in Today’s "Cell"
NEW YORK, NY August 11, 2021. Pediatric lupus expert...
Pressroom
Recent Press Releases
Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca’s anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)
First in New Class of Drugs in More than a Decade for SLE Targeting Type 1 Interferons
NEW YORK, NY....
The Lupus Research Alliance Awards 2021 Lupus Insight Prize to Immunologist Dr. Martin Kriegel
Research Is First to Pinpoint a Gut Organism to Lupus, Advancing Understanding of the Microbiome in Autoimmune Disease
NEW YORK,...
Former Jets Player Willie Colon Hosts NJ Event with Support from Other Pro Athletes, Raising Nearly $300,000 for Lupus Research Alliance
SUMMIT, NJ -- May 3, 2021. In honor of May, Lupus Awareness Month, former Super Bowl Champion and Barstool...
Groundbreaking New Study in Lancet Rheumatology Shows Potential Strategy for Safer Steroid Use in Lupus
Dr. Eric Morand Publishes Results Funded by LRA’s Distinguished Innovator Award
NEW YORK, NY. March 31, 2021. Results of critical...
Lupus Research Alliance Announces 2020 Distinguished Innovator Awards Aimed at New Lupus Treatments
NEW YORK, March 25, 2021 — The Lupus Research Alliance proudly announces two exceptional recipients of the 2020 Dr. William...
JDRF, Lupus Research Alliance, and National Multiple Sclerosis Society Join Forces to Decode Common Mechanisms of Autoimmune Diseases
First Joint Common Mechanisms Grants Announced
NEW YORK, NY, February 24, 2021 – JDRF International, the Lupus Research Alliance...
Lupus Research Alliance Hails Approval of Aurinia’s Lupkynis(TM) (voclosoporin)
First Oral Treatment for Lupus Nephritis;
Second Lupus Treatment to Receive FDA Approval in Past Month
NEW YORK, NY. January...
LRA Pleased to Share GSK’s Benlysta® (belimumab) is First Lupus Nephritis Treatment Approved by FDA
NEW YORK, NY. December 17, 2020. The Lupus Research Alliance (LRA) congratulates GSK on the U.S. Food and Drug...
Over Half of People with Lupus Would Take COVID-19 Vaccine, Shows LRA Survey
Updated January 4, 2021
New York, NY– December 16, 2020. More than half of people with lupus (54%) are willing...
New Survey Shows Education and Communication Gaps in Lupus Nephritis Care
1 in 2 Lupus Nephritis Patients Don’t Know They Have Lupus
New York, NY– December 7, 2020. Significant gaps in...
LRA’s 2020 LMTA Grantees Focus on Finding Targets for New Lupus Drug Development
NEW YORK, NY. December 3, 2020 - The Lupus Research Alliance is proud to announce the 2020 recipients of...